Showing results (21-30 of 703) with videos related to
Sort By:
Pageof 71
Genes, Chromosomes & Cancer|January 19, 1999
Genetic characterization of HHV-8/KSHV-positive primary effusion lymphoma reveals frequent mutations of BCL6: implications for disease pathogenesis and histogenesisG Gaidano, D Capello, A M Cilia, et al.Haematologica|May 1, 1991
Molecular diagnosis of Philadelphia chromosome-positive chronic myeloid leukemiaA Zaccaria, A Tassinari, A Guerrasio, et al.Haematologica|May 1, 1997
The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemiasF Lo Coco, S Pisegna, D DiverioLeukemia|October 3, 2002
Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patientsD Cilloni, E Gottardi, D De Micheli, et al.Leukemia|July 1, 1992
Transient cytogenetic relapse in a Ph1-positive chronic myelogenous leukemia patient previously treated with alpha-interferonG Rege-Cambrin, A Guerrasio, P Scaravaglio, et al.Haematologica|December 29, 1998
Therapy of acute myeloid leukemia: towards a patient-oriented, risk-adapted approachF Mandelli, M C Petti, F Lo CocoGenes, Chromosomes & Cancer|August 1, 1997
Genetic lesions associated with blastic transformation of polycythemia vera and essential thrombocythemiaG Gaidano, C Pastore, V Santini, et al.British Journal of Haematology|February 1, 1997
Multigenetic lesions in infant acute leukaemias: correlations with ALL-1 gene statusG Cimino, C Lanza, L Elia, et al.Leukemia & Lymphoma|February 1, 1994
Clinical relevance of the PML/RAR-a gene rearrangement in acute promyelocytic leukaemiaF Lo Coco, P G Pelicci, A BiondiLeukemia|June 1, 2002
Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcriptsA Guerrasio, C Pilatrino, D De Micheli, et al.Pageof 71